ES2076201T3 - Derivados de 3-piperidinil-indazol antihipertensivos. - Google Patents

Derivados de 3-piperidinil-indazol antihipertensivos.

Info

Publication number
ES2076201T3
ES2076201T3 ES89202152T ES89202152T ES2076201T3 ES 2076201 T3 ES2076201 T3 ES 2076201T3 ES 89202152 T ES89202152 T ES 89202152T ES 89202152 T ES89202152 T ES 89202152T ES 2076201 T3 ES2076201 T3 ES 2076201T3
Authority
ES
Spain
Prior art keywords
alkyl
hypertensives
indazol
substituted
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89202152T
Other languages
English (en)
Inventor
Jan Vandenberk
Ludo Edmond Josephine Kennis
Heertum Albertus H M T Van
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Janssen Pharmaceutica NV
Original Assignee
Janssen Pharmaceutica NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica NV filed Critical Janssen Pharmaceutica NV
Application granted granted Critical
Publication of ES2076201T3 publication Critical patent/ES2076201T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/12—Antidiarrhoeals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D513/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00
    • C07D513/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups C07D463/00, C07D477/00 or C07D499/00 - C07D507/00 in which the condensed system contains two hetero rings
    • C07D513/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Psychiatry (AREA)
  • Addiction (AREA)
  • Pain & Pain Management (AREA)
  • Obesity (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

NUEVOS DERIVADOS DE 3-PIPERIDIL-INDAZOL ANTIHIPERTENSIVOS DE FORMULA (I), DONDE R1 ES H O ALQUILO C1-C6; R2 ES H, ALQUILO C1-C6, ALQUILO C1-C6 SUSTITUIDO, FENILO OPCIONALMENTE SUSTITUIDO, ALQUILCARBONILO C1-C6, ALQUILOXICARBONILO O FENILCARBONILO C1-C6, DONDE EL FENILO PUEDE ESTAR SUSTITUIDO, R3 Y R4 SON H, HALO, HIDROXI, ALQUILOXI C1-C6 O ALQUILO C1-C6; Q ES UN RADICAL HETEROCICLICO BICICLICO DE FORMULA (A), (B) O (C), LAS SALES DE ADICION DE ACIDO FARMACEUTICAMENTE ACEPTABLES Y SUS POSIBLES FORMAS ESTEREOQUIMICAMENTE ISOMERAS, COMPUESTOS QUE SON AGENTES ANTIHIPERTENSIVOS; COMPOSICIONES FARMACEUTICAS QUE TIENEN TALES COMPUESTOS COMO INGREDIENTE ACTIVO, Y METODOS PARA PREPARAR DICHOS COMPUESTOS Y COMPOSICIONES FARMACEUTICAS.
ES89202152T 1988-09-02 1989-08-25 Derivados de 3-piperidinil-indazol antihipertensivos. Expired - Lifetime ES2076201T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US23991588A 1988-09-02 1988-09-02

Publications (1)

Publication Number Publication Date
ES2076201T3 true ES2076201T3 (es) 1995-11-01

Family

ID=22904291

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89202152T Expired - Lifetime ES2076201T3 (es) 1988-09-02 1989-08-25 Derivados de 3-piperidinil-indazol antihipertensivos.

Country Status (21)

Country Link
EP (1) EP0357134B1 (es)
JP (1) JP2768992B2 (es)
KR (1) KR0145705B1 (es)
CN (1) CN1024346C (es)
AT (1) ATE124410T1 (es)
AU (1) AU614871B2 (es)
CA (1) CA1331610C (es)
DE (1) DE68923231T2 (es)
DK (1) DK169547B1 (es)
ES (1) ES2076201T3 (es)
FI (1) FI91864C (es)
GR (1) GR3017435T3 (es)
HU (1) HU202232B (es)
IE (1) IE66511B1 (es)
IL (1) IL90879A0 (es)
NO (1) NO176608C (es)
NZ (1) NZ230367A (es)
PH (1) PH26456A (es)
PT (1) PT91613B (es)
SU (1) SU1720489A3 (es)
ZA (1) ZA896741B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5364866A (en) 1989-05-19 1994-11-15 Hoechst-Roussel Pharmaceuticals, Inc. Heteroarylpiperidines, pyrrolidines and piperazines and their use as antipsychotics and analetics
US5776963A (en) 1989-05-19 1998-07-07 Hoechst Marion Roussel, Inc. 3-(heteroaryl)-1- (2,3-dihydro-1h-isoindol-2-yl)alkyl!pyrrolidines and 3-(heteroaryl)-1- (2,3-dihydro-1h-indol-1-yl)alkyl!pyrrolidines and related compounds and their therapeutic untility
DE4414113A1 (de) * 1994-04-22 1995-10-26 Merck Patent Gmbh 3-Indolylpiperidine
JPWO2004069828A1 (ja) * 2003-02-04 2006-05-25 三菱ウェルファーマ株式会社 ピペリジン化合物およびその医薬用途
JP7090639B2 (ja) * 2017-04-11 2022-06-24 サンシャイン・レイク・ファーマ・カンパニー・リミテッド フッ素置換されたインダゾール化合物及びその使用

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4335127A (en) * 1979-01-08 1982-06-15 Janssen Pharmaceutica, N.V. Piperidinylalkyl quinazoline compounds, composition and method of use
US4342870A (en) * 1980-03-28 1982-08-03 Janssen Pharmaceutica N.V. Novel 3-(1-piperidinylalkyl)-4H-pyrido[1,2-a]pyrimidin-4-one derivatives
US4443451A (en) * 1981-07-15 1984-04-17 Janssen Pharmaceutica N.V. Bicyclic pyrimidin-5-one derivatives
JPS58159480A (ja) * 1982-03-17 1983-09-21 Chugai Pharmaceut Co Ltd 新規なフエニルピペラジン誘導体
US4485107A (en) * 1982-11-01 1984-11-27 Janssen Pharmaceutica N.V. [[Bis(aryl)methylene]-1-piperidinyl]alkyl-pyrimidinones
US4670447A (en) * 1983-08-22 1987-06-02 Hoechst-Roussel Pharmaceuticals Inc. Antipsychotic 3-(piperidinyl)- and 3-(pyrrolidinyl)-1H-indazoles
HU198036B (en) * 1983-08-22 1989-07-28 Hoechst Roussel Pharma Process for production of derivatives of 3-piperidil-/1h/-indasole and medical preparatives containing them
US4716161A (en) * 1984-04-17 1987-12-29 Mitsubishi Chemical Industries Limited Phenylpiperazine derivatives and their acid addition salts
CA1246074A (en) * 1984-12-05 1988-12-06 Albertus H.M.T. Van Heertum Derivatives of hydroxy- or amino-substituted (piperidinylalkyl)quinazolines
ATE61054T1 (de) * 1985-01-23 1991-03-15 Hoechst Roussel Pharma 3-piperidinyl- 1h-indazole, verfahren zu deren herstellung und deren anwendung als arzneimittel.
US4804663A (en) * 1985-03-27 1989-02-14 Janssen Pharmaceutica N.V. 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles
US4711883A (en) * 1985-09-30 1987-12-08 Ortho Pharmaceutical Corporation Substituted 3-(4-phenyl-1-piperazinyl)alkylquinazolin-2,4-(1H,3H) diones, methods of preparation, compositions and method of use
NZ223654A (en) * 1987-03-09 1990-03-27 Janssen Pharmaceutica Nv 1-alkyl-substituted-benzimidazole-4-piperidinamines and pharmaceutical compositions
CA1317939C (en) * 1987-07-01 1993-05-18 Janssen Pharmaceutica Naamloze Vennootschap ¬(bicyclic heterocyclyl)methyl and -hetero| substituted hexahydro-1h-azepines and pyrrolidines

Also Published As

Publication number Publication date
ZA896741B (en) 1991-05-29
ATE124410T1 (de) 1995-07-15
EP0357134B1 (en) 1995-06-28
DE68923231D1 (de) 1995-08-03
IE66511B1 (en) 1996-01-10
PH26456A (en) 1992-07-27
NO893523L (no) 1990-03-05
CA1331610C (en) 1994-08-23
JP2768992B2 (ja) 1998-06-25
PT91613A (pt) 1990-03-30
GR3017435T3 (en) 1995-12-31
NO176608B (no) 1995-01-23
CN1040589A (zh) 1990-03-21
EP0357134A1 (en) 1990-03-07
HU202232B (en) 1991-02-28
KR900004721A (ko) 1990-04-12
DK434789D0 (da) 1989-09-01
AU4084889A (en) 1990-03-08
NZ230367A (en) 1991-03-26
JPH02160778A (ja) 1990-06-20
CN1024346C (zh) 1994-04-27
FI91864B (fi) 1994-05-13
FI894125A7 (fi) 1990-03-03
HUT51622A (en) 1990-05-28
FI894125A0 (fi) 1989-09-01
KR0145705B1 (ko) 1998-08-17
DE68923231T2 (de) 1995-11-09
DK434789A (da) 1990-03-03
IE892829L (en) 1990-03-02
FI91864C (fi) 1994-08-25
DK169547B1 (da) 1994-11-28
PT91613B (pt) 1995-05-04
IL90879A0 (en) 1990-02-09
NO893523D0 (no) 1989-09-01
AU614871B2 (en) 1991-09-12
NO176608C (no) 1995-05-03
SU1720489A3 (ru) 1992-03-15

Similar Documents

Publication Publication Date Title
NO159017C (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive 1,2,3,4-tetrahydroisokinolin-3-karboksylsyre-derivater.
ES2055860T3 (es) Derivados 2-aminopirimidinona.
DK0620216T3 (da) Benzamidderivater og deres anvendelse som vasopressinantagonister
ES2123039T3 (es) Nuevas 3-(hidroxi-bencilidenil)-indolin-2-onas, su procedimiento de preparacion y composiciones farmaceuticas que las contienen.
NZ238181A (en) N-(1-substituted-piperidinyl(alkyl))carbamic acid, urea and carboxamide derivatives and homologues thereof; preparatory processes and pharmaceutical compositions
ES8606306A1 (es) Un procedimiento para preparar nuevos derivados de benzo- triazol- y benzoxazolamina
AR245866A1 (es) Composiciones herbicidas de 1,3-dicarbonil acilado y antidotos para las mismas.
UY25332A1 (es) Compuestos de indol 2,3-sustituidos como agentes anti-inflamatorios y analgésicos
MA21381A1 (fr) Nouveau n-(1 alkyl-3-hydroxy-4-piperidyl)
PT97395A (pt) Processo para a preparacao de 2,9-di-substituidas-4h-pirido{1,2-a}-pirimidin-4-onas e de composicoes farmaceuticas que os contem
ES2074462T3 (es) Derivados 3-piperazinil-benzazoles antipsicoticos.
ES2134237T3 (es) Composiciones farmaceuticas que contienen acido ursodesoxicolico.
DK1233953T3 (da) Nye benzoethiadiazinderivater, fremgangsmåde til fremstilling heraf og farmaceutiske sammensætninger indeholdende samme
DE68904102D1 (de) Antivirale tetrahydroimidazo(1,4)benzodiazepin-2-one.
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
ES2065192T3 (es) Nuevos nicotinatos de diacil-glicerol, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ATE124410T1 (de) Antihypertensive 3-piperidinylindazol-derivate.
MX9203068A (es) Compuestos activirales oralmente activos.
FI864099A0 (fi) Nya , -diaryl-4-aryl-4-hydroxi-1 -piperidin-butanamid-n-oxider.
YU45994A (sh) Farmaceutski preparati za prevenciju i/ili tretiranje gastrointenstinalnih oboljenja uključujući ulkus
ES2094935T3 (es) N-hidroxiacetamidas y n-hidroxiureas ciclopropilicas que inhiben la lipoxigenasa.
ES2123038T3 (es) Nuevos derivados pirrolo-tieno-pirazinicos, su procedimiento de preparacion y composiciones farmaceuticas que los contienen.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 357134

Country of ref document: ES